Spring
2005 Advances in Pulmonary Hypertension medical
journal now online
Articles include:
--Defining the Role and Clinical Relevance of BMPR2
Mutations in Pulmonary Arterial Hypertension
--TGF-beta Receptors in Pulmonary Arterial Hypertension: The HHT
Connection
--The Serotonin Pathway in Pulmonary Hypertension
--Potential Genetic Contributions to Nonidiopathic, Nonfamilial
Pulmonary Hypertension
--The Future of Genetics in Pulmonary Arterial Hypertension
Interactive Breathing Device Found
Effective in Lowering High Systolic Blood Pressure
Frost & Sullivan has awarded its 2005 Hypertension Treatment
Technology Innovation of the Year Award to InterCure, Inc. for
its pioneering Interactive Respiratory-Pacing technology, and
in particular for its device RESPeRATE To Lower Blood Pressure® -
the only FDA-cleared non-drug medical device clinically proven
to lower high blood pressure. The Award has been presented at
the 2nd annual Excellence in Medical Devices Awards Banquet.
Cholesterol-lowering agents, such as the widely-prescribed statin drugs, and cholesterol-blocking agents may prove to be “novel therapeutic agents to modify cellular calcium that contributes to the development of pulmonary hypertension,” according to Hemal H. Patel, who leads a multidisciplinary team of researchers at the UCSD School of Medicine.
Pulmonary
Hypertension - A Patient's Survival Guide The premiere information resource
for people dealing with PH -- written by patients for patients!!!
The author, a PH patient herself,
knows what it is like to live with the disease. She talked to many
other patients, doctors, and researchers while writing the Survival
Guide. Dr. Ronald J. Oudiz and a team of physicians with a deep
knowledge of PH edited the book for accuracy.
New edition contains a chart
of 15 drugs used to treat PH; results of recent
clinical trials;
in-depth discussion of PH secondary to other diseases
or conditions;
a new chapter on what to eat if you have PH; and much, much more!
ISLAMABAD, April 06 (Online): An ingredient in garlic appears to prevent a potentially deadly type of high blood pressure affecting the lungs, at least in rats, according to new research.
Children of mothers with preeclampsia more likely to have pulmonary hypertension
Children born of mothers who had preeclampsia during their pregnancy are more likely to have pulmonary hypertension than similar children born from normal pregnancies, according to a study conducted in Bolivia by Swiss and Bolivian researchers. The findings provide the first evidence that preeclampsia (pregnancy-induced hypertension) can leave a persistent and potentially fatal imprint in the pulmonary circulation of the fetus, a physiological change that can predispose the offspring to exaggerated hypoxic pulmonary hypertension in later life.
The
information provided on the PHA website is provided for general information
only. It is not intended as legal, medical or other professional
advice, and should not be relied upon as a substitute for consultations
with qualified professionals who are familiar with your individual
needs.
